Startups for Shades That Produce Solar Power and Proton Therapy Visualization Win CHF 40,000 Each
29.01.2020
Discover the two winning projects iWin and Terapet that each receives 40,000 francs and entrepreneurial training from Venture Kick.
 |
 |
 iWin CEO Rubén Roldán Molinero and CPO Paoli Corti
|
|
 TERAPET co-founders Christina Vallgren and Marcus Palm
|
|
iWin: Proptech / Shading device producing clean energy
Buildings today consume still too much energy and have huge margin of improvement. IWin aims at improving the solar protection of the buildings, reducing the cooling energy and producing renewable energy within the window. They have developed and patented an innovative window solution that integrates thin, flexible film photovoltaic cells into window blinds, without compromising the design and the operation of the system. It protect buildings from overheating in the summer, reduces energy bills and produces renewable electricity. IWin is durable, thanks to its integration inside double-glazing units, and repays the initial cost in less than 10 years, faster than any other rival blind solution. They overcame the proof of concept phase and have deposited their first international patent. The first working prototype have been validated thanks to simulation analysis and the support of measurements. With their industrial partner, they validated the market number and the manufacturing feasibility together with a CIGS photovoltaic manufacturer. The Venture Kick funds will be used to finance in part the activities related to the implementation of the business plan like meetings, market analysis, scouting of competitors, surveys or participation to exhibition.
TERAPET: real-time tracking of proton therapy dosage-delivery
Proton radiotherapy uses high-energy particles to treat cancer. Currently, with no way to track live dosage-delivery, doctors either damage healthy cells by exposing more tissue than necessary, or reject patients who might benefit from treatment. To solve this, TERAPET's detector measures the gamma rays emitted as a by-product of proton therapy to make a precise, 3D-visualization of the treated region in real-time. The co-founding team of CERN-physicists Christina Vallgren and Marcus Palm, and Geneva University Hospitals' head radiologist Raymond Miralbell, hope their patented innovation will make cancer treatment safer, more precise and quicker.